**
Recent research reveals alarming levels of per- and polyfluoroalkyl substances (PFAS), commonly referred to as ‘forever chemicals’, in umbilical cord blood, suggesting fetuses are exposed to a wider array of these harmful compounds than previously recognised. A comprehensive study conducted by Mount Sinai uncovered 42 distinct PFAS compounds in samples taken from 120 umbilical cords, highlighting significant implications for fetal health during a critical developmental period.
Comprehensive Analysis Reveals Hidden Risks
Traditionally, testing for PFAS in umbilical cord blood has focused on a limited number of well-known compounds, such as perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS). However, with over 15,000 known PFAS chemicals in existence, researchers at Mount Sinai adopted a more exhaustive “non-targeted analysis” approach, which allowed them to identify a broader spectrum of these substances.
The findings indicate that the total concentration of PFAS in fetal blood is significantly higher than earlier estimates suggested. According to Shelley Liu, an associate professor at the Icahn School of Medicine and co-author of the study, “Babies are exposed to many more PFAS than we previously thought.” This increased exposure during such a vulnerable stage of development raises urgent questions about potential health ramifications.
The Health Risks Associated with PFAS
PFAS are widely used in a variety of consumer products due to their water-, stain-, and grease-resistant properties. However, these chemicals have been linked to a myriad of serious health issues, including cancer, developmental disorders, weakened immune responses, and chronic conditions such as high cholesterol and kidney disease. Their nickname, ‘forever chemicals’, stems from their persistence in the environment and the human body; they do not break down easily.
A review encompassing 40 studies found PFAS in 30,000 umbilical cord blood samples, emphasising the prevalence of these toxic substances. Notably, elevated PFAS levels in mothers have been correlated with increased infant mortality rates, lower birth weights, and obesity later in life. Moreover, fetal exposure has been associated with long-term health challenges, including neurological disorders and cardiovascular diseases.
Regulatory Oversight Struggling to Keep Pace
Despite the growing body of evidence regarding the dangers posed by PFAS, regulatory frameworks remain inadequate. The US Environmental Protection Agency (EPA) typically assesses only 30 to 40 PFAS compounds in water samples, often missing many others identified by independent researchers. A 2022 analysis highlighted this undercounting issue, raising concerns about the effectiveness of current regulatory practices.
The Mount Sinai study juxtaposed traditional testing methods with the expanded non-targeted analysis, revealing that the latter detected significantly more PFAS compounds. Although the EPA has recently approved a blood testing method for 53 PFAS compounds, the Mount Sinai research found 31 compounds that are not included in the EPA’s list. This discrepancy underscores the urgent need for enhanced testing and regulatory measures.
Implications for Future Research and Health Policies
While the Mount Sinai study did not directly link PFAS exposure to specific health issues, Liu noted that higher blood levels are generally associated with elevated health risks. The blood samples analysed were part of a federal initiative tracking PFAS exposure and its health impacts throughout individuals’ lives, suggesting a potential avenue for further research into the long-term effects of prenatal exposure to these chemicals.
David Andrews, acting chief science officer at the Environmental Working Group, emphasised the study’s significance, stating, “This paper is a stark reminder of the importance of health-protective regulations and how lax oversight can result in babies being born pre-polluted with harmful chemicals such as PFAS.”
Why it Matters
The discovery of elevated PFAS levels in umbilical cord blood highlights a critical public health concern, particularly for vulnerable populations such as expectant mothers and their unborn children. As the science surrounding these chemicals evolves, it is paramount that regulatory bodies adapt their approaches to ensure the safety and wellbeing of future generations. This research serves as a clarion call for enhanced scrutiny and protective measures, as the implications of prenatal exposure could reverberate through generations. Addressing this issue is not just a matter of scientific inquiry; it is a pressing moral obligation to safeguard public health.
